Sales & Marketing Bad KOL data is expensive: Harnessing high-quality data for ... As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.
Partner Content Partner Content Overwhelmed with KOL Data how to navigate through KOL insights & management
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.